The dilemma of drug development for heart failure: when is the time to initiate large clinical trials?
Massie
Barry M
BM
D002316:Cardiotonic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000379:methods*; D015195:Drug Design; D065128:Endothelin Receptor Antagonists; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D013678:Technology, Pharmaceutical / Q000458:organization & administration
D002316:Cardiotonic Agents; D065128:Endothelin Receptor Antagonists